SEATTLE, WA / ACCESSWIRE / July 2, 2024 / MD Clarity today announced it has been named High Performer in G2’s Summer 2024 Grid® Report. High Performers are earned based on receiving high customer satisfaction ratings compared to others in their category on G2, the world’s largest software review marketplace.
Overall, MD Clarity earned a total of five accolades on G2, including:
High Performer
Best Support
Best Relationship
Easiest To Do Business With
Best Meets Requirements.
“Our G2 High Performer recognition affirms the substantial impact our product has on both provider reimbursement and patient financial experience,” said Dan Freeman, MD Clarity’s CEO. “The Best Support, Best Relationship, and Easiest to Do Business With awards all speak to our status as the revenue optimization software of choice for Management Services Organizations (MSOs) and large physician-owned groups whose financial complexity makes enterprise-grade support a must.”
To see MD Clarity’s customer ratings, visit MD Clarity’s review listing page on G2.
About MD Clarity
MD Clarity is a powerful software platform transforming the revenue cycle of healthcare organizations. Through pre-service patient estimates and deposits, automated detection of variances between payer payments and contracted rates, and managed care agreement rate benchmarking and scenario modeling, MD Clarity enables the Revenue Cycle and Finance teams of healthcare organizations to boost their cash flow. With a decade-long track record capturing the complexities of managed care agreements within its software platform, MD Clarity has grown to serve more than 150,000 providers. For more information, visit MDClarity.com or follow MD Clarity on LinkedIn.
Contact Information
David Freeman
Director of Strategy
david.freeman@mdclarity.com
SOURCE: MD Clarity
View the original press release on newswire.com.
View the original press release on accesswire.com
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best…
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…